Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

The association of CXCR3 and renal cell carcinoma metastasis.

Utsumi T, Suyama T, Imamura Y, Fuse M, Sakamoto S, Nihei N, Ueda T, Suzuki H, Seki N, Ichikawa T.

J Urol. 2014 Aug;192(2):567-74. doi: 10.1016/j.juro.2014.01.100. Epub 2014 Feb 8.

PMID:
24518777
2.

CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma.

Gacci M, Serni S, Lapini A, Vittori G, Alessandrini M, Nesi G, Palli D, Carini M.

J Urol. 2009 Feb;181(2):843-8. doi: 10.1016/j.juro.2008.10.063. Epub 2008 Dec 17.

PMID:
19095263
3.
4.

Expression of CXCR3 on mononuclear cells and CXCR3 ligands in patients with metastatic renal cell carcinoma in response to systemic IL-2 therapy.

Reckamp KL, Figlin RA, Moldawer N, Pantuck AJ, Belldegrun AS, Burdick MD, Strieter RM.

J Immunother. 2007 May-Jun;30(4):417-24.

PMID:
17457216
5.

Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression.

Datta D, Contreras AG, Grimm M, Waaga-Gasser AM, Briscoe DM, Pal S.

J Am Soc Nephrol. 2008 Dec;19(12):2437-46. doi: 10.1681/ASN.2008040394. Epub 2008 Oct 2.

6.

The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma.

Klatte T, Seligson DB, Leppert JT, Riggs SB, Yu H, Zomorodian N, Kabbinavar FF, Strieter RM, Belldegrun AS, Pantuck AJ.

J Urol. 2008 Jan;179(1):61-6. Epub 2007 Nov 13.

PMID:
17997430
7.

CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.

Zipin-Roitman A, Meshel T, Sagi-Assif O, Shalmon B, Avivi C, Pfeffer RM, Witz IP, Ben-Baruch A.

Cancer Res. 2007 Apr 1;67(7):3396-405.

8.

CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1.

Datta D, Banerjee P, Gasser M, Waaga-Gasser AM, Pal S.

J Biol Chem. 2010 Nov 19;285(47):36842-8. doi: 10.1074/jbc.M110.170324. Epub 2010 Sep 20.

9.

Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.

Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

Clin Cancer Res. 2007 Dec 15;13(24):7388-93.

10.
11.
12.

MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression.

Aubert S, Fauquette V, Hémon B, Lepoivre R, Briez N, Bernard D, Van Seuningen I, Leroy X, Perrais M.

Cancer Res. 2009 Jul 15;69(14):5707-15. doi: 10.1158/0008-5472.CAN-08-4905. Epub 2009 Jun 23.

13.

MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.

Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H.

J Urol. 2013 Sep;190(3):1059-68. doi: 10.1016/j.juro.2013.02.089. Epub 2013 Feb 27.

PMID:
23454155
14.

Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.

Shoji S, Tang XY, Umemura S, Itoh J, Takekoshi S, Shima M, Usui Y, Nagata Y, Uchida T, Osamura RY, Terachi T.

Eur Urol. 2009 Feb;55(2):441-9. doi: 10.1016/j.eururo.2008.02.048. Epub 2008 Mar 11.

PMID:
18395325
15.

Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.

Zhang G, Zhang Z, Liu Z.

Tumour Biol. 2013 Jun;34(3):1887-94. doi: 10.1007/s13277-013-0732-0. Epub 2013 Mar 14.

PMID:
23494182
16.

Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.

Kawada K, Sonoshita M, Sakashita H, Takabayashi A, Yamaoka Y, Manabe T, Inaba K, Minato N, Oshima M, Taketo MM.

Cancer Res. 2004 Jun 1;64(11):4010-7.

17.

Myoglobin expression in renal cell carcinoma is regulated by hypoxia.

Behnes CL, Bedke J, Schneider S, Küffer S, Strauss A, Bremmer F, Ströbel P, Radzun HJ.

Exp Mol Pathol. 2013 Dec;95(3):307-12. doi: 10.1016/j.yexmp.2013.09.003. Epub 2013 Sep 25.

PMID:
24076247
18.

TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor.

Shang D, Liu Y, Yang P, Chen Y, Tian Y.

Urology. 2012 Apr;79(4):966.e1-7. doi: 10.1016/j.urology.2011.12.011. Epub 2012 Feb 15.

PMID:
22341602
19.

Hypoxia-inducible factor (HIF)-independent expression mechanism and novel function of HIF prolyl hydroxylase-3 in renal cell carcinoma.

Tanaka T, Torigoe T, Hirohashi Y, Sato E, Honma I, Kitamura H, Masumori N, Tsukamoto T, Sato N.

J Cancer Res Clin Oncol. 2014 Mar;140(3):503-13. doi: 10.1007/s00432-014-1593-7. Epub 2014 Jan 30.

PMID:
24477694
20.

Expression and role of HMGA1 in renal cell carcinoma.

Takaha N, Sowa Y, Takeuchi I, Hongo F, Kawauchi A, Miki T.

J Urol. 2012 Jun;187(6):2215-22. doi: 10.1016/j.juro.2012.01.069. Epub 2012 Apr 13.

PMID:
22503056
Items per page

Supplemental Content

Write to the Help Desk